HEADER HYDROLASE 08-JUL-97 1WED OBSLTE 27-MAY-98 1WED 2WED TITLE ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX TITLE 2 WITH PHOSPHONATE MACROCYCLIC INHIBITOR: METHYL[CYCLO- TITLE 3 7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1- TITLE 4 METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1- TITLE 5 NAPHTHALENEACETAMIDE] SODIUM SALT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLOPEPSIN; COMPND 3 CHAIN: NULL; COMPND 4 EC: 3.4.23.20 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PENICILLIUM JANTHINELLUM; SOURCE 3 ORGANISM_COMMON: FUNGUS KEYWDS HYDROLASE, PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, ASPARTYL KEYWDS 2 PROTEASE, GLYCOSYLATED PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.DING,M.N.G.JAMES REVDAT 1 14-JAN-98 1WED 0 JRNL AUTH J.DING,M.E.FRASER,J.H.MEYER,P.A.BARTLETT, JRNL AUTH 2 M.N.G.JAMES JRNL TITL X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PENICILLOPEPSIN JRNL TITL 2 COMPLEXED WITH A P3-P1 MACROCYCLIC PEPTIDYL JRNL TITL 3 PHOSPHONATE INHIBITOR AND COMPARISON WITH TWO JRNL TITL 4 ACYCLIC ANALOGUES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.H.MEYER,P.A.BARTLETT REMARK 1 TITL MACROCYCLIC INHIBITOR OF PENICILLOPEPSIN. I. REMARK 1 TITL 2 DESIGN, SYNTHESIS, AND EVALUATION OF AN INHIBITOR REMARK 1 TITL 3 BRIDGED BETWEEN P1 AND P3 REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH M.E.FRASER,N.C.STRYNADKA,P.A.BARTLETT,J.E.HANSON, REMARK 1 AUTH 2 M.N.JAMES REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE REMARK 1 TITL 2 MIMICS BOUND TO PENICILLOPEPSIN: REMARK 1 TITL 3 PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES REMARK 1 REF BIOCHEMISTRY V. 31 5201 1992 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.N.JAMES,A.R.SIELECKI,K.HAYAKAWA,M.H.GELB REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE REMARK 1 TITL 2 MIMICS BOUND TO PENICILLOPEPSIN: REMARK 1 TITL 3 DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING REMARK 1 TITL 4 PEPTIDES REMARK 1 REF BIOCHEMISTRY V. 31 3872 1992 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5E REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 3 NUMBER OF REFLECTIONS : 36649 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD :NULL REMARK 3 FREE R VALUE TEST SET SELECTION :NULL REMARK 3 R VALUE (WORKING + TEST SET) :0.161 REMARK 3 R VALUE (WORKING SET) :0.158 REMARK 3 FREE R VALUE :0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) :10.000 REMARK 3 FREE R VALUE TEST SET COUNT :NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1660 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1630 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 38650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2394 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : NULL REMARK 3 SOLVENT ATOMS : 332 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 13.640 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.013 ; 1.000 ; NULL REMARK 3 BOND ANGLES (DEGREES) : 1.431 ; 1.000 ; NULL REMARK 3 TORSION ANGLES (DEGREES) : 15.458; 15.000; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.021 ; 2.000 ; NULL REMARK 3 GENERAL PLANES (A) : 0.021 ; 3.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : 0.079 ; 9.000 ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.64 REMARK 3 BSOL : 148.59 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: X-PLOR, TNT ESD FROM SIGMAA (A) : REMARK 3 0.149658 UNCERTAINTY IN RMS ERROR SQUARED : 0.002037 REMARK 4 REMARK 4 1WED COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-FEB-1997 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 4.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ROTATING ANODE GENERATOR WITH REMARK 200 COPPER TARGET REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : DOUBLE-MIRRORS FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : DIP2030H IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38650 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 METHOD REMARK 200 SOFTWARE USED: X-PLOR AND TNT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 1/2+X,1/2+Y,Z REMARK 290 4555 1/2-X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.94000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.32000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.94000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.32000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O HOH 216 O HOH 217 2.06 REMARK 500 O HOH 85 O HOH 165 2.11 REMARK 500 OD2 ASP 222 O HOH 260 2.18 REMARK 500 O HOH 204 O HOH 205 2.19 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL 155 CB VAL 155 CG1 -0.118 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER 55 N - CA - C ANGL. DEV. =-11.3 DEGREES REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 188 DISTANCE = 5.26 ANGSTROMS REMARK 525 HOH 200 DISTANCE = 5.71 ANGSTROMS REMARK 525 HOH 217 DISTANCE = 5.05 ANGSTROMS REMARK 525 HOH 235 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH 243 DISTANCE = 5.72 ANGSTROMS REMARK 525 HOH 248 DISTANCE = 5.77 ANGSTROMS REMARK 525 HOH 272 DISTANCE = 7.12 ANGSTROMS REMARK 525 HOH 274 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH 275 DISTANCE = 5.08 ANGSTROMS REMARK 525 HOH 278 DISTANCE = 5.58 ANGSTROMS REMARK 525 HOH 281 DISTANCE = 5.71 ANGSTROMS REMARK 525 HOH 282 DISTANCE = 8.52 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 THIS ENTRY IS RELATED TO PDB ENTRIES 1WEA, 1WEB, 1WEC. DBREF 1WED 1 323 UNP P00798 PENP_PENJA 1 323 SEQADV 1WED GLU 133 UNP P00798 GLN 133 CONFLICT SEQADV 1WED ASP 222 UNP P00798 ASX 222 CONFLICT SEQADV 1WED ALA 313 UNP P00798 ASP 313 CONFLICT SEQRES 1 323 ALA ALA SER GLY VAL ALA THR ASN THR PRO THR ALA ASN SEQRES 2 323 ASP GLU GLU TYR ILE THR PRO VAL THR ILE GLY GLY THR SEQRES 3 323 THR LEU ASN LEU ASN PHE ASP THR GLY SER ALA ASP LEU SEQRES 4 323 TRP VAL PHE SER THR GLU LEU PRO ALA SER GLN GLN SER SEQRES 5 323 GLY HIS SER VAL TYR ASN PRO SER ALA THR GLY LYS GLU SEQRES 6 323 LEU SER GLY TYR THR TRP SER ILE SER TYR GLY ASP GLY SEQRES 7 323 SER SER ALA SER GLY ASN VAL PHE THR ASP SER VAL THR SEQRES 8 323 VAL GLY GLY VAL THR ALA HIS GLY GLN ALA VAL GLN ALA SEQRES 9 323 ALA GLN GLN ILE SER ALA GLN PHE GLN GLN ASP THR ASN SEQRES 10 323 ASN ASP GLY LEU LEU GLY LEU ALA PHE SER SER ILE ASN SEQRES 11 323 THR VAL GLU PRO GLN SER GLN THR THR PHE PHE ASP THR SEQRES 12 323 VAL LYS SER SER LEU ALA GLN PRO LEU PHE ALA VAL ALA SEQRES 13 323 LEU LYS HIS GLN GLN PRO GLY VAL TYR ASP PHE GLY PHE SEQRES 14 323 ILE ASP SER SER LYS TYR THR GLY SER LEU THR TYR THR SEQRES 15 323 GLY VAL ASP ASN SER GLN GLY PHE TRP SER PHE ASN VAL SEQRES 16 323 ASP SER TYR THR ALA GLY SER GLN SER GLY ASP GLY PHE SEQRES 17 323 SER GLY ILE ALA ASP THR GLY THR THR LEU LEU LEU LEU SEQRES 18 323 ASP ASP SER VAL VAL SER GLN TYR TYR SER GLN VAL SER SEQRES 19 323 GLY ALA GLN GLN ASP SER ASN ALA GLY GLY TYR VAL PHE SEQRES 20 323 ASP CYS SER THR ASN LEU PRO ASP PHE SER VAL SER ILE SEQRES 21 323 SER GLY TYR THR ALA THR VAL PRO GLY SER LEU ILE ASN SEQRES 22 323 TYR GLY PRO SER GLY ASP GLY SER THR CYS LEU GLY GLY SEQRES 23 323 ILE GLN SER ASN SER GLY ILE GLY PHE SER ILE PHE GLY SEQRES 24 323 ASP ILE PHE LEU LYS SER GLN TYR VAL VAL PHE ASP SER SEQRES 25 323 ALA GLY PRO GLN LEU GLY PHE ALA PRO GLN ALA MODRES SER 3 SER GLYCOSYLATION SITE MODRES THR 7 THR GLYCOSYLATION SITE MODRES 1WED SER 3 SER GLYCOSYLATION SITE MODRES 1WED THR 7 THR GLYCOSYLATION SITE HET MAN 324 11 HET MAN 325 11 HET SO4 283 5 HET PP6 326 45 HETNAM MAN ALPHA-D-MANNOSE HETNAM SO4 SULFATE ION HETNAM PP6 METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)- HETNAM 2 PP6 1-METHYLOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY- HETNAM 3 PP6 ETHYL]-1-NAPHTHALENEACETAMIDE] FORMUL 2 MAN 2(C6 H12 O6) FORMUL 4 SO4 O4 S 2- FORMUL 5 PP6 C29 H32 N2 O7 P 1- FORMUL 6 HOH *282(H2 O1) HELIX 1 1 ALA 12 ASP 14 5 3 HELIX 2 2 ALA 48 GLN 51 1 4 HELIX 3 3 PRO 59 THR 62 1 4 HELIX 4 4 ALA 110 GLN 114 1 5 HELIX 5 5 SER 127 ILE 129 5 3 HELIX 6 6 PHE 140 SER 147 1 8 HELIX 7 7 SER 172 LYS 174 5 3 HELIX 8 8 ASP 223 GLN 232 1 10 HELIX 9 9 GLY 269 ILE 272 1 4 HELIX 10 10 ASP 300 SER 305 1 6 SHEET 1 A10 LEU 39 VAL 41 0 SHEET 2 A10 GLY 120 GLY 123 -1 N LEU 121 O TRP 40 SHEET 3 A10 THR 26 ASP 33 1 N ASN 31 O LEU 122 SHEET 4 A10 TYR 17 ILE 23 -1 N ILE 23 O THR 26 SHEET 5 A10 GLY 4 PRO 10 -1 N THR 9 O ILE 18 SHEET 6 A10 GLY 163 PHE 167 -1 N PHE 167 O GLY 4 SHEET 7 A10 LEU 152 ALA 156 -1 N ALA 156 O VAL 164 SHEET 8 A10 GLN 306 ASP 311 -1 N PHE 310 O PHE 153 SHEET 9 A10 GLN 316 PRO 321 -1 N ALA 320 O TYR 307 SHEET 10 A10 THR 180 GLY 183 -1 N THR 182 O LEU 317 SHEET 1 B 3 THR 70 SER 74 0 SHEET 2 B 3 SER 80 ASP 88 -1 N GLY 83 O TRP 71 SHEET 3 B 3 GLN 100 ILE 108 -1 N GLN 107 O SER 82 SHEET 1 C 2 VAL 90 VAL 92 0 SHEET 2 C 2 VAL 95 ALA 97 -1 N ALA 97 O VAL 90 SHEET 1 D 3 SER 192 VAL 195 0 SHEET 2 D 3 PHE 208 ALA 212 -1 N GLY 210 O PHE 193 SHEET 3 D 3 SER 296 PHE 298 1 N SER 296 O ILE 211 SHEET 1 E 4 GLN 203 ASP 206 0 SHEET 2 E 4 SER 197 ALA 200 -1 N ALA 200 O GLN 203 SHEET 3 E 4 PHE 256 ILE 260 -1 N SER 259 O SER 197 SHEET 4 E 4 TYR 263 VAL 267 -1 N VAL 267 O PHE 256 SHEET 1 F 2 LEU 219 LEU 221 0 SHEET 2 F 2 ILE 287 SER 289 1 N GLN 288 O LEU 219 SHEET 1 G 4 GLN 237 ASP 239 0 SHEET 2 G 4 GLY 244 ASP 248 -1 N VAL 246 O GLN 237 SHEET 3 G 4 THR 282 GLY 285 -1 N CYS 283 O PHE 247 SHEET 4 G 4 ASN 273 PRO 276 -1 N GLY 275 O LEU 284 SSBOND 1 CYS 249 CYS 283 LINK C1 MAN 324 OG SER 3 LINK C1 MAN 325 OG1 THR 7 CISPEP 1 GLU 133 PRO 134 0 -0.67 CISPEP 2 GLY 314 PRO 315 0 -7.00 CRYST1 97.880 46.640 66.590 90.00 116.14 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010217 0.000000 0.005014 0.00000 SCALE2 0.000000 0.021441 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016728 0.00000